RIMEAlgorhythm Holdings, Inc.
The schedule
- Thu22Oct
In a bid to unlock residual value, RIME officially explores strategic alternatives, including the piecemeal sale of its intellectual property or a discounted merger.
- Sun16May
Q3 results dictate RIME's viability entering the crucial holiday retail season, focusing on channel distribution and inventory absorption.
- Mon16Aug
Past
- Fri14Aug
Actual outcome: Bear
Algorhythm Holdings reported Q2 2026 results with EPS matching estimates and revenue growing 161% year-over-year to $3.0 million. Despite the significant top-line growth, the stock fell 17.4% following the print, indicating that the revenue figures were insufficient to alleviate broader market concerns regarding the company's ongoing profitability and strategic restructuring efforts.
RIME delivers its Q2 2026 financial print, testing management's ability to halt the severe top-line decay in its core consumer electronics portfolio.
- Tue28Jul
Actual outcome: Bear · $0.41 at outcome
RIME executed an emergency equity capital raise and recapitalization to address near-term debt refinancing hurdles and stave off insolvency. The highly dilutive nature of the secondary offering, combined with confirmation of the company's severe financial distress, drove the stock lower as existing shareholders absorbed the impact on equity value.
RIME executes an emergency equity capital raise to stave off insolvency and address near-term debt refinancing hurdles.
- Thu18Jun
Actual outcome: Bear · $0.58 at outcome
Algorhythm Holdings faced an expected Nasdaq minimum bid deficiency notice as its share price broke structural support below the $1.00 threshold. Although the company announced its subsidiary SemiCab would showcase its platform at an industry event, the looming delisting threat and structural breakdown drove significant selling pressure, causing the stock to drop over 20% by the outcome date.
An expected formal Nasdaq deficiency notice is issued as RIME's share price breaks structural support below the $1.00 minimum bid requirement.
- Thu14May
Actual outcome: Bear · $0.68 at outcome
Algorhythm Holdings reported a 71% sequential increase in Q1 revenue and an improved cash balance of nearly $11 million, alongside an expanded $4.2 million contract with Procter & Gamble India. However, despite meeting EPS estimates and alleviating immediate liquidity concerns, the stock failed to gain traction and fell below the $0.75 bear floor, indicating that the market remained skeptical about the company's underlying cash burn and long-term profitability.
RIME reports Q1 2026 earnings with a critical focus on its deteriorating liquidity position, as cash balances stood at just $1.6M against a heavy $1.3M quarterly operating burn.
